Applied Clinical Trials Magazine

Our November issue is LIVE! Enhancing Empowerment in Patient-Focused Research🔺Addressing the Health Literacy Roadblock in Patient Recruitment🔺How to Balance Data and Trust🔺and so much more right here: https://lnkd.in/eWX3Gmbc

The emergence of AI-powered simulants in improving study efficiency. 🖊️Mandis Beigi, Senior Director; Afrah Shafquat, Senior Staff Data Scientist; Jia Chen, PhD, Senior Director, Medidata AI; Jacob Aptekar, Vice President; and Yahav Itzkovich, Senior Engagement Manager; all with Medidata Solutions

Mick R., vice president of IT at ICON plc, discusses the growing use of #artificialintelligence in #clinicalresearch — from technology and #dataanalysis to #patientprivacy and ethics.

In a recent video interview with Applied Clinical Trials Magazine, our CTO Jeff S. discussed current challenges in clinical research technology. He highlighted the overabundance of systems and emphasized the need for integration to streamline processes and reduce administrative overhead, as well as artificial intelligence's potential to automate repetitive tasks, enhancing efficiency and quality. Check it out here: https://lnkd.in/gT5TgJgn #ClinicalResearch #ClinicalTrials #HealthcareInnovation #AI

📹 In this video interview, Mark Melton, vice president of biospecimen data and operations, Slope, talks secure #datatransfer and risk mitigation.

The Phase III AALL1731 trial demonstrated that adding Blincyto (blinatumomab) to chemotherapy significantly improved three-year disease-free survival in pediatric patients with standard-risk B-cell acute lymphoblastic leukemia.

In this article with Applied Clinical Trials Magazine, Martin Wing-King, VP and General Manager at our Reading facility, discusses the complexity of bringing new treatments to market and how demand for accelerated pathways to first-in-human trials is growing across the #pharmaceutical industry. https://lnkd.in/eXgmBD23

Discover how to implement technology that supports sponsors, sites, patients, and caregivers—key to clinical trial success in 2025. Read the article and explore site survey results here: https://hubs.ly/Q02_0r_50 Drew Bustos, Applied Clinical Trials Magazine, Tiffany McGinnis #eCOA #eConsent #ePRO #ClinicalTrialTech #DigitalHealth #ClinicalResearch

Interim results from the lead-in cohort showed some patients who received LP-300 alongside #chemotherapy experienced an average tumor size reduction of 51%.

Scott Palmese, executive director, site relationships and DCT solutions, Worldwide Clinical Trials, discusses the practice of incorporating decentralized elements in a study rather than planning a decentralized trial from the start.